About Zinc finger protein 772
Zinc finger protein 772 (ZNF772) is a protein
from Homo sapiens identified by UniProt accession
Q68DY9, 489 residues long.
MolForge cross-references it against 0 known binders and
10 disease associations.
Target properties
| Protein name | Zinc finger protein 772 |
| UniProt accession | Q68DY9 |
| Gene | ZNF772 |
| Organism | Homo sapiens |
| Length | 489 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (10)
Diseases linked to this target (Open Targets).
- prostate cancer · score 0.11
- Familial prostate cancer · score 0.11
- prostate carcinoma · score 0.11
- squamous cell carcinoma · score 0.01
- Sepsis · score 0.01
- Pallister-Hall syndrome · score 0.00
- infection · score 0.00
- infect · score 0.00
- neoplasm · score 0.00
- hypopharyngeal carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q68DY9-F1 | alphafold | PREDICTED | 64.73 | — |
Amino-acid sequence (489 residues)
MAAAEPMGPA QVPMNSEVIV DPIQGQVNFE DVFVYFSQEE WVLLDEAQRL LYRDVMLENF ALMASLGHTS FMSHIVASLV MGSEPWVPDW VDMTLAVATE TPGGSDPGCW HGMEDEEIPF EQSFSIGMSQ IRIPKGGPST QKAYPCGTCG LVLKDILHLA EHQETHPGQK PYMCVLCGKQ FCFSANLHQH QKQHSGEKPF RSDKSRPFLL NNCAVQSMEM SFVTGEACKD FLASSSIFEH HAPHNEWKPH SNTKCEEASH CGKRHYKCSE CGKTFSRKDS LVQHQRVHTG ERPYECGECG KTFSRKPILA QHQRIHTGEM PYECGICGKV FNHSSNLIVH QRVHTGARPY KCSECGKAYS HKSTLVQHES IHTGERPYEC SECGKYFGHK YRLIKHWSVH TGARPYECIA CGKFFSQSSD LIAHQRVHNG EKPYVCSECG KAFSHKHVLV QHHRIHTGER PYKCSECGKA FRQRASLIRH WKIHTGERP
Explore Zinc finger protein 772 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets